Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

How HIV works news


From To
Video SNiP: PET Scan “Hot Spots” Help Visualize Inflammatory Complication of HIV

Infectious-disease and radiology researchers from NIAID and the NIH Clinical Center are working together to visualize and predict HIV-associated immune reconstitution syndrome (IRIS) in a new way—with positron emission tomography (PET). The researchers describe their findings in a paper published this week in Clinical Infectious Diseases and in a new NIAID Video SNiP.

14 September 2018
National Institute of Allergy and Infectious Diseases
Why has HIV in Saskatchewan become more harmful for some people?

Reports have suggested that HIV may be progressing more rapidly in Saskatchewan. Researchers analyzed the genetic sequences of HIV among people in the province. They discovered strains of HIV that have adapted to some people’s immune defences.

22 August 2018
Mutated strains of HIV in Saskatchewan causing illness quicker: study

Research suggests mutated strains of HIV circulating in Saskatchewan are leading to faster-developing AIDS-related illnesses among Indigenous people.

27 July 2018
Calgary Herald
ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

For virologically suppressed patients infected with HIV, switching to a dual antiretroviral maintenance therapy of atazanavir/ritonavir plus lamivudine does not affect plasma markers of systemic inflammation, according to results published in the Journal of Antimicrobial Chemotherapy.

15 June 2018
Infectious Disease Advisor
HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

NIH study results represent major advance for structure-based HIV vaccine design.

05 June 2018
National Institutes of Health (press release)
New findings on inflammation & how it affects people with HIV

“There is a large set of adverse events that HIV-infected individuals suffer from that appear to be associated with inflammation,” lead study author Brian Hart told BETA. “These events are relatively common and can affect length and quality of life.”

27 April 2018
BETA blog
Has Basic Science in HIV Research Stalled?

Now that effective therapies for active HIV infection are broadly available, there should be renewed focus on basic science regarding HIV, said experts contacted by MedPage Today.

09 April 2018
MedPage Today
How HIV Alters Cells May Facilitate Sexual Transmission of Hepatitis C

A new study identifies key changes that HIV makes to Langerhans cells in the mucosal lining of the rectum.

22 March 2018
Statement of UNAIDS on news reports of a new HIV strain in the Philippines

UNAIDS is concerned that media reports which make reference to HIV research in the Philippines are being interpreted as saying that there is a new and untreatable strain of the virus in the country. There is no new strain of HIV which has been found in the Philippines.

21 March 2018
UNAIDS Asia-Pacific
Inflammation, HIV and marijuana

This issue of TreatmentUpdate focuses on the impact of cannabinoids on the immune system.

13 March 2018
← First12345...35Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.